- Home
- NRIM vs SIGA Comparison
NRIM vs SIGA Comparison
Compare NRIM & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIM
- SIGA
- Stock Information
- Founded
- NRIM 1990
- SIGA 1995
- Country
- NRIM United States
- SIGA United States
- Employees
- NRIM N/A
- SIGA N/A
- Industry
- NRIM Savings Institutions
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- NRIM Finance
- SIGA Health Care
- Exchange
- NRIM Nasdaq
- SIGA Nasdaq
- Market Cap
- NRIM 514.9M
- SIGA 515.1M
- IPO Year
- NRIM N/A
- SIGA 1997
- Fundamental
- Price
- NRIM $91.29
- SIGA $8.92
- Analyst Decision
- NRIM
- SIGA
- Analyst Count
- NRIM 0
- SIGA 0
- Target Price
- NRIM N/A
- SIGA N/A
- AVG Volume (30 Days)
- NRIM 42.9K
- SIGA 508.6K
- Earning Date
- NRIM 10-22-2025
- SIGA 11-06-2025
- Dividend Yield
- NRIM 2.78%
- SIGA 6.71%
- EPS Growth
- NRIM 38.28
- SIGA N/A
- EPS
- NRIM 7.99
- SIGA 1.14
- Revenue
- NRIM $175,041,000.00
- SIGA $179,639,422.00
- Revenue This Year
- NRIM N/A
- SIGA N/A
- Revenue Next Year
- NRIM $8.63
- SIGA $115.06
- P/E Ratio
- NRIM $11.53
- SIGA $7.85
- Revenue Growth
- NRIM 28.34
- SIGA 3.86
- 52 Week Low
- NRIM $63.68
- SIGA $4.95
- 52 Week High
- NRIM $100.21
- SIGA $9.62
- Technical
- Relative Strength Index (RSI)
- NRIM 51.61
- SIGA 60.00
- Support Level
- NRIM $89.73
- SIGA $8.49
- Resistance Level
- NRIM $92.95
- SIGA $9.09
- Average True Range (ATR)
- NRIM 1.80
- SIGA 0.32
- MACD
- NRIM -0.14
- SIGA -0.02
- Stochastic Oscillator
- NRIM 26.53
- SIGA 72.28
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.